PIIIW · P3 Health Partners Inc.
Substantial doubt about the company's ability to continue as a going concern.
“As of the date of this Form 10-Q, we believe that our existing cash resources are not sufficient to support planned operations for at least the next year from the issuance of the unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q. As a result, we have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date the unaudited condensed consolidated financial statements included elsewhere in this Form 10-Q are issued.”View the 10-Q filed Aug 10, 2026
Price & Indicators
The closing range uses available history since Jul 23, 2026; less than a full year is stored.
Up next
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders illustrative — not investment adviceIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA (loss) non-GAAP | 80.2M | Six Months Ended June 30 | — |
| Adjusted EBITDA (loss) PMPM non-GAAP | $127 | Six Months Ended June 30 | — |
| Adjusted EBITDA PMPM non-GAAP | $173 | Q2 2026 | — |
| Adjusted operating expense non-GAAP | 56.25M | Six Months Ended June 30 | — |
| At-risk members | 105,000 | Q2 2026 | — |
| Average at-risk members | 104,800 | the three months ended June 30, 2026 filing | — |
| Medical margin non-GAAP | 171.46M | Six Months Ended June 30 | — |
| Medical margin PMPM non-GAAP | $271 | Six Months Ended June 30 | — |
| Platform support costs | $26.97M | the three months ended June 30, 2026 filing | — |
| Platform support costs as % of total operating revenue | 7% | the three months ended June 30, 2026 filing | — |
| Total lives under management | 133,000 | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PIIIW
this stock
P3 Health Partners Inc.
|
$29.84M | — | -2.8% | — | — |
|
HCA
HCA Healthcare, Inc.
|
$101.91B | +0.1% | +7.1% | 15.4 | 2.2% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$28.97B | -10.3% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.49B | +36.2% | +0.9% | 10.3 | 2.3% |
|
EHC
Encompass Health Corp
|
$11.88B | +18.7% | +10.5% | 19.6 | 3.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 79.1%
- Reported
- 2 of 35
- Top holder
- LMR Partners LLP
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PIIIW | +38.0% | +58.1% | — | +29.0% | — |
| SPY | -1.0% | -0.4% | +6.0% | +0.2% | +12.0% |
| vs SPY | +39.0% | +58.5% | — | +28.8% | — |